U.S., July 18 -- ClinicalTrials.gov registry received information related to the study (NCT07711782) titled 'Management of Polycystic Ovarian Syndrome-associated Reproductive Dysfunction Through Kefir Supplementation' on July 13.
Brief Summary: Polycystic ovary syndrome (PCOS) affect around 6-12% of women of age 18-25 years. Kefir contains bioactive compounds such as lactic acid bacteria, yeast, peptides, polysaccharides and organic acids and acts as a good probiotic source.
Study Start Date: Jan. 18
Study Type: INTERVENTIONAL
Condition:
Polycystic Ovarian Syndrome (PCOS)
Reproductive Health
Intervention:
OTHER: (C0) Control group
Participants were subjected to use a regular calorie deficit diet plan
DIETARY_SUPPLEMENT: (G1) Experi...